Literature DB >> 28529324

A novel combination strategy for effectively targeting cancer stem-like cells.

Paul A Beavis1,2, Emma V Petley1,2, Phillip K Darcy1,2,3,4.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28529324     DOI: 10.1038/icb.2017.39

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  6 in total

1.  Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

Authors:  Jesse M Zaretsky; Angel Garcia-Diaz; Daniel S Shin; Helena Escuin-Ordinas; Willy Hugo; Siwen Hu-Lieskovan; Davis Y Torrejon; Gabriel Abril-Rodriguez; Salemiz Sandoval; Lucas Barthly; Justin Saco; Blanca Homet Moreno; Riccardo Mezzadra; Bartosz Chmielowski; Kathleen Ruchalski; I Peter Shintaku; Phillip J Sanchez; Cristina Puig-Saus; Grace Cherry; Elizabeth Seja; Xiangju Kong; Jia Pang; Beata Berent-Maoz; Begoña Comin-Anduix; Thomas G Graeber; Paul C Tumeh; Ton N M Schumacher; Roger S Lo; Antoni Ribas
Journal:  N Engl J Med       Date:  2016-07-13       Impact factor: 91.245

2.  Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.

Authors:  Daniel Sanghoon Shin; Jesse M Zaretsky; Helena Escuin-Ordinas; Angel Garcia-Diaz; Siwen Hu-Lieskovan; Anusha Kalbasi; Catherine S Grasso; Willy Hugo; Salemiz Sandoval; Davis Y Torrejon; Nicolaos Palaskas; Gabriel Abril Rodriguez; Giulia Parisi; Ariel Azhdam; Bartosz Chmielowski; Grace Cherry; Elizabeth Seja; Beata Berent-Maoz; I Peter Shintaku; Dung T Le; Drew M Pardoll; Luis A Diaz; Paul C Tumeh; Thomas G Graeber; Roger S Lo; Begoña Comin-Anduix; Antoni Ribas
Journal:  Cancer Discov       Date:  2016-11-30       Impact factor: 39.397

3.  Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.

Authors:  Annedore Respa; Juergen Bukur; Soldano Ferrone; Graham Pawelec; Yingdong Zhao; Ena Wang; Francesco M Marincola; Barbara Seliger
Journal:  Clin Cancer Res       Date:  2011-01-19       Impact factor: 12.531

Review 4.  Immune Checkpoint Blockade in Cancer Therapy.

Authors:  Michael A Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

Review 5.  How tumours escape mass destruction.

Authors:  T J Stewart; S I Abrams
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

Review 6.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

  6 in total
  1 in total

1.  Exploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remission.

Authors:  Piyali Ganguli; Ram Rup Sarkar
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.